Patient Registry Software Market to Grow with a CAGR of 9.57% through 2030
The
growing emphasis on healthcare data interoperability to improve patient care
coordination, coupled with regulatory mandates promoting electronic health
record (EHR) integration with registry platforms, is expected to
drive the Global Patient Registry Software Market growth in the forecast
period, 2026-2030
According to
TechSci Research report, “Patient Registry Software Market – Global Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2030F”,
the Global Patient Registry Software Market stood at USD 2.11 Billion in
2024 and is expected to reach USD 3.66 Billion by 2030 with a CAGR of 9.57% during
the forecast period. This can be due to
collaborations and partnerships among leading companies with a diverse approach
to merge the expertise of individual companies and to strengthen their position
in the market. The integration of telehealth solutions is a driver for the Global
Patient Registry Software Market. Telehealth, which encompasses telemedicine
and virtual healthcare services, has experienced significant growth and
adoption, especially in recent years. The integration of patient registry
software with telehealth services offers several advantages and opportunities,
contributing to the demand for patient registry solutions. Telehealth solutions
often include remote patient monitoring capabilities. Patient registry software
can integrate with telehealth platforms to collect and manage patient data
generated through remote monitoring devices, ensuring that all relevant data is
included in the patient registry. By integrating with telehealth services,
patient registry software can provide a more comprehensive view of a patient's
health. This includes data from in-person visits as well as telehealth
consultations, enabling healthcare providers to make more informed decisions. Telehealth
consultations generate valuable patient data, such as vital signs, symptoms,
and treatment adherence. Integrating this data into patient registries enhances
the completeness and richness of the patient records, which is particularly
beneficial for managing chronic conditions.
In April 2022, the first of its type in the United States, the Registry Science Practice will focus on developing registry programs for patients, physicians, and researchers. Quantori, LLC, a leading global provider of data science and digital IT services for biopharma and healthcare, announced the opening of the practice. To track long-term health outcomes and improve the delivery of evidence-based care, registry science is a burgeoning field of medical informatics and biostatistics that overlaps with medicine and epidemiology. The American College of Medical Informatics (ACMI) Fellow and well-known clinician-informatician Steven Labkoff will lead Quantori's Registry Science Practice in serving healthcare and research organizations by building and managing registries that offer long-term data collection and analytics capabilities that are typically not feasible with unimodal data sets, such as EHRs alone. The Registry Science Practice will give clinicians and researchers the tools they need to use data-driven evidence, which is only achievable when looking across several datasets, to make the most informed healthcare decisions.
Interoperability issues have been a significant challenge in the Global Patient Registry Software Market. Interoperability refers to the ability of different healthcare information systems and software applications to seamlessly exchange, access, and use patient data while maintaining its integrity and security. Healthcare organizations use a variety of software systems, including Electronic Health Records (EHRs), Laboratory Information Systems (LIS), Picture Archiving and Communication Systems (PACS), and more. These systems often operate in silos with different data formats and standards, making it difficult to integrate patient registry software. Different healthcare IT systems may use varying data formats, coding systems (e.g., ICD-10, SNOMED CT), and medical terminologies. Harmonizing these differences to ensure that patient data can be exchanged accurately is a complex task. Integrating patient registry software with existing healthcare IT systems can be technically challenging and resource intensive. It may require custom interfaces and data transformation processes.
Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " Global Patient Registry Software Market”
The Global Patient Registry Software Market segmentation
is based on type of registry, type of software, end user, regional distribution, and company.
Based on the Type
of Registry, Disease Registries emerged as the fastest growing segment in the Global
Patient Registry Software Market during the forecast period. This is due to their crucial role in managing
chronic and rare diseases. With the rising prevalence of conditions such as
cancer, diabetes, cardiovascular diseases, and autoimmune disorders, healthcare
providers are increasingly relying on disease-specific registries to track
patient data, monitor treatment outcomes, and improve care coordination. These
registries facilitate real-time data collection, enabling healthcare
professionals to analyze disease trends, identify risk factors, and optimize
treatment strategies. Governments and research institutions are also promoting
disease registries to enhance public health surveillance, support clinical
research, and drive evidence-based policymaking.
Based
on the Region, Asia-Pacific emerged as the fastest growing region in the Global
Patient Registry Software Market during
the forecast period. This is due to the increasing number of clinical research
activities and the rising adoption of artificial intelligence (AI) in
healthcare. Pharmaceutical companies and research institutions are leveraging
patient registry software to streamline clinical trials, manage large datasets,
and ensure regulatory compliance. The region is also home to a rapidly
expanding biotechnology and pharmaceutical industry, which relies on registries
for post-market surveillance, drug development, and epidemiological studies.
Moreover, the rise of telemedicine and remote patient monitoring solutions has
further accelerated the adoption of digital health platforms, reinforcing the
demand for patient registry software. The combination of government support,
private sector investment, and technological advancements positions
Asia-Pacific as the fastest-growing region in this market.
Some of the major companies operating in the Global Patient Registry Software Market include:
- Dacima Software Inc.
- FIGmd Inc.
- Global Vision Technologies Inc.
- Image Trend Inc.
- IQVIA
- Ordinal Data, Inc.
- McKensson Corporation
- Syneos Health
- Velos Inc.
- Cerner Corporation
Download Free Sample Report
Customers can also request 10% free customization on this report
“The Global
Patient Registry Software Market is expanding due to the growing emphasis on
real-world evidence (RWE) in healthcare decision-making, driving the adoption
of advanced registry solutions. Regulatory agencies and pharmaceutical
companies increasingly rely on RWE derived from patient registries to assess
treatment effectiveness, monitor long-term drug safety, and support regulatory
approvals. This shift is fostering greater investments in robust data
collection and analysis tools within patient registries. Additionally,
healthcare providers are leveraging RWE to enhance clinical guidelines and
optimize patient outcomes, further fueling market growth. As the demand for
evidence-based healthcare rises, patient registry software is becoming
indispensable for generating actionable insights.,” said Mr. Karan Chechi,
Research Director of TechSci Research, a research-based management consulting
firm.
“Patient Registry
Software Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, Segmented By Type of Registry (Disease Registries, Health Service
Registries, Product Registries), By Type of Software (Stand-alone Software,
Integrated Software), By End User (Hospitals, Government Organizations and
Third-Party Administrators (TPAs), Pharmaceutical, Biotechnology, and Medical
Device Companies, Other), By Region and Competition, 2020-2030F”,
has evaluated the future growth potential of Global Patient Registry Software
Market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Patient Registry
Software Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com